The ninth annual BIO-Europe
Spring® conference will be held March 9–11, 2015 in
Paris, France at the Paris expo Porte de Versailles conference center.
This is the first time Paris will host a life science industry event of
this scale, and it is expected to draw a large number of established
biotech and early stage companies desiring to form business partnerships
with investors and big pharma companies.
Pharmaceutical giant Sanofi is a major sponsor of the event, as well as
Laboratoires Servier and Sofinnova Ventures. The event is the largest
springtime life science partnering conference. The event brings investor
and pharma partners together with life science companies to forge deals
that ultimately transform the healthcare market.
The one-to-one meetings that take place at BIO-Europe Spring between
potential partners have broad ranging benefits for the drug development
pipeline. These meetings are an effective business strategy enabling
life science companies to meet and present to numerous potential
partners. The program is also geared toward partnerships, where industry
thought leaders speak on topics ranging from tough issues faced by drug
developers, to regulatory hurdles to funding and commercialization
strategies.
“Paris is an ideal location for BIO-Europe Spring,” said Anna Chrisman,
Group Managing Director, EBD Group. “Paris is one of the largest life
science clusters in Europe, well-known for its culture of excellence,
from basic research and discovery at the universities all the way to
drug development for major diseases.”
The Paris region brings together seven innovation clusters enhancing
life science innovation. The number one region for developing startups
in Western Europe, Paris is also a leader in oncology, neurosciences,
infectious diseases and cardiology research and therapy with prestigious
institutions such as the Curie Institute, the Gustave Roussy (the number
one center in Europe for early stage cancer therapies), the Brain and
Spine Institute, and the Pasteur Institute (the leading microbiology
research center in Europe) to name just a few. Over 1,000 life science
companies are located in the Paris Region, and over 500 international
companies have a base in Paris.
“It speaks to the growth of the Paris region as a bio innovation hub
that BIO-Europe Spring, a world-class industry event, is coming to Paris
in March,” said Jean-Roch Meunier, CEO of Medicen Paris Region.
“Paris is a leading center for disease research and health technologies,
with an environment ripe with partnering opportunities.”
“We are very excited to host BIO-Europe Spring 2015 in Paris, as we are
an extremely active cluster and have many partnerships with companies in
Europe, America and Asia,” said Nathalie Desnoyer, International
Life Sciences Director from the Paris Region Economic Development
Agency. “It makes sense to bring them all together in March to discover
what’s new in Paris and the many international business opportunities
for collaboration.”
In 2014, BIO-Europe Spring was held in Turin, Italy, where over 2,000
attendees from 1,209 companies participated in 10,780 one-to-one
meetings involving 2,115 licensing opportunities. BIO-Europe Spring will
continue to provide life science companies with high caliber partnering
opportunities in Paris, France.
Register
before January 20, 2015, and save EUR 200 off the regular registration
fee.
At BIO-Europe Spring, companies participate in one-to-one partnering
meeting facilitated by EBD Group’s highly reputable partneringONE®
platform. partneringONE is EBD Group’s sophisticated, web-based
partnering system that enables event delegates to efficiently identify,
meet and get partnerships started with companies across the life science
value chain, from large biotech and pharma companies to financiers and
innovative startups.
About BIO-Europe
Spring® 2015:
As the springtime counterpart to BIO-Europe®, BIO-Europe
Spring® continues the tradition of providing life science
companies with high caliber partnering opportunities. Featuring EBD
Group’s acclaimed partnering system, partneringONE®, the
event enables delegates to efficiently identify, meet and get
partnerships started with companies across the biotech value chain.
In addition to productive partnering, BIO-Europe Spring offers high
level workshops, panels, company presentations, and a lively exhibition.
The program features executive level panelists who openly share their
insight and opinion on many important industry issues. The company
presentation tracks provide a forum for innovative startups, established
biotech companies, and large and midsize pharma to present information
on products, partnering opportunities and corporate strategy.
Combined, these elements create an insightful and productive event that
will have you coming back year after year.
BIO-Europe Spring is produced by EBD Group, the leading partnering firm
for the global biotechnology industry, with the support of the
Biotechnology Industry Organization (BIO).
Follow BIO-Europe Spring 2015 on Twitter: twitter.com/ebdgroup
(hashtag: #BES15). Or log on to the BIO-Europe
Spring 2015 Discussion Forum on partnering360®. The
Group is your go-to discussion forum for news and topics related to
BIO-Europe Spring.
About EBD Group
EBD Group is the leading partnering firm for the global life science
industry. Since 1993, biotech, pharma and medical device companies have
leveraged EBD Group’s partnering conferences, technology and services to
identify business opportunities and develop strategic relationships
essential to their success.
EBD Group’s conferences are run with the support of leading corporations
and international trade associations and include:
-
BIO-Europe®
and
BIO-Europe Spring®, Europe’s largest life science
partnering conferences, supported by the Biotechnology Industry
Organization (BIO)
-
BioPharm
America™, the fastest growing partnering event in North America
-
Biotech
Showcase™, a unique forum in San Francisco for presenting to
investors and business development executives, co-produced with
Demy-Colton Life Science Advisors
-
BioEquity
Europe, the investor conference co-organized with BioCentury
Publications and BIO
-
ChinaBio®
Partnering Forum, the first dedicated biotech/pharma partnering
conference in China, co-produced with ChinaBio® LLC
-
Medtech Partnering Forum Japan, EBD Group’s partnering event for the
innovative medical technology industry
-
The Global
Impact Forum™, a unique and innovative partnering conference in
impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®,
is used as the partnering engine at numerous third-party events around
the world, and partnering360®
is the open online community of life science dealmakers that enhances
partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned
organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20141216006133/en/
Copyright Business Wire 2014